debrisoquin has been researched along with Craniocerebral Trauma in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Craniocerebral Trauma: Traumatic injuries involving the cranium and intracranial structures (i.e., BRAIN; CRANIAL NERVES; MENINGES; and other structures). Injuries may be classified by whether or not the skull is penetrated (i.e., penetrating vs. nonpenetrating) or whether there is an associated hemorrhage.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hörtnagl, H | 1 |
| Hammerle, AF | 1 |
| Hackl, JM | 1 |
1 other study available for debrisoquin and Craniocerebral Trauma
| Article | Year |
|---|---|
[Hypermetabolism in head injury and tetanus: patho-physiological and new therapeutic conceptions].
Topics: Adrenergic beta-Antagonists; Catecholamines; Craniocerebral Trauma; Debrisoquin; Drug Therapy, Combi | 1980 |